CHPA issues statement on FDA’s proposed rule for additional conditions for nonprescription use
WASHINGTON — CHPA’s president and CEO, Scott Melville, today released the following statement in response to the FDA releasing a proposed rule on “Nonprescription Drug Product with an Additional Condition for Nonprescription Use” (ACNU): “CHPA is pleased the FDA has issued this long-awaited proposed rule. Prescription to over-the-counter switches for certain pharmaceutical ingredients (“Rx-to-OTC switch”) have
